Should I buy or sell Hyperfine stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hyperfine in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HYPR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HYPR, but not buy additional shares or sell existing shares. View HYPR analyst ratings or view top-rated stocks .

What is Hyperfine's stock price target for 2024?

3 Wall Street research analysts have issued twelve-month target prices for Hyperfine's shares. Their HYPR share price targets range from $1.25 to $3.50. On average, they predict the company's share price to reach $2.12 in the next twelve months. This suggests a possible upside of 155.0% from the stock's current price. View analysts price targets for HYPR or view top-rated stocks among Wall Street analysts .

How have HYPR shares performed in 2024?

Hyperfine's stock was trading at $1.12 at the beginning of 2024. Since then, HYPR stock has decreased by 25.9% and is now trading at $0.83. View the best growth stocks for 2024 here .

When is Hyperfine's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our HYPR earnings forecast .

How were Hyperfine's earnings last quarter?

Hyperfine, Inc. (NASDAQ:HYPR) announced its quarterly earnings data on Thursday, March, 21st. The company reported ($0.15) EPS for the quarter, beating analysts' consensus estimates of ($0.17) by $0.02. The business earned $2.69 million during the quarter, compared to analysts' expectations of $3.66 million. Hyperfine had a negative trailing twelve-month return on equity of 44.89% and a negative net margin of 401.00%.

What guidance has Hyperfine issued on next quarter's earnings?

Hyperfine updated its FY 2024 earnings guidance on Thursday, March, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $12.0 million-$15.0 million, compared to the consensus revenue estimate of $18.4 million.

How do I buy shares of Hyperfine?

Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:HYPR

Hyperfine (HYPR) Stock Price, News & Analysis

→ Will this $2 AI stock double overnight? (From Behind the Markets) (Ad)

Free HYPR Stock Alerts

$0.83

+0.02 (+2.47%)

(As of 04:00 PM ET)

Compare

Today's Range: $0.82
▼
$0.90
50-Day Range: $0.81
▼
$1.25
52-Week Range: $0.80
▼
$3.28

Volume: 56,505 shs
Average Volume: 69,966 shs
Market Capitalization: $59.72 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.12

Get Hyperfine alerts:

Hyperfine MarketRank™ Stock Analysis

Analyst Rating: Hold
2.33 Rating Score
Upside/Downside: 155.0% Upside
$2.12 Price Target
Short Interest: Bearish
2.81% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.00
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.53) to ($0.50) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.06 out of 5 stars

Medical Sector

775th out of 911 stocks

Electromedical Equipment Industry

16th out of 19 stocks

3.2

Analyst's Opinion

Consensus Rating
Hyperfine has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Hyperfine has only been the subject of 1 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
2.81% of the float of Hyperfine has been sold short.
Short Interest Ratio / Days to Cover
Hyperfine has a short interest ratio ("days to cover") of 18.3, which indicates bearish sentiment.
Change versus previous month
Short interest in Hyperfine has recently increased by 3.20%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Hyperfine does not currently pay a dividend.
Dividend Growth
Hyperfine does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for HYPR.

0.6

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 2 news articles for Hyperfine this week, compared to 1 article on an average week.
MarketBeat Follows
3 people have added Hyperfine to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Hyperfine insiders have not sold or bought any company stock.
Percentage Held by Insiders
26.50% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 15.03% of the stock of Hyperfine is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Hyperfine are expected to grow in the coming year, from ($0.53) to ($0.50) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Hyperfine is -1.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Hyperfine is -1.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Hyperfine has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Behind the Markets

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

Click here to learn more >>>

About Hyperfine Stock (NASDAQ:HYPR)

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

HYPR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HYPR Stock News Headlines

April 17, 2024 | msn.com

Hyperfine (HYPR) Price Target Decreased by 6.02% to 1.33

April 17, 2024 | businesswire.com

Leading Institutions Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study

April 19, 2024 | Behind the Markets (Ad)

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

March 23, 2024 | markets.businessinsider.com

Challenges Ahead: Revising Hyperfine’s Outlook Amid Lower-than-Expected Financial Performance

March 22, 2024 | msn.com

Hyperfine, Inc. (NASDAQ:HYPR) Q4 2023 Earnings Call Transcript

March 21, 2024 | investorplace.com

HYPR Stock Earnings: Hyperfine Beats EPS, Misses Revenue for Q4 2023

March 21, 2024 | benzinga.com

Recap: Hyperfine Q4 Earnings

March 21, 2024 | globenewswire.com

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

April 19, 2024 | Behind the Markets (Ad)

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

March 12, 2024 | finance.yahoo.com

Hyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal

March 12, 2024 | businesswire.com

Hyperfine, Inc. Collaborates with King's College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal

March 7, 2024 | businesswire.com

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024

February 28, 2024 | finance.yahoo.com

Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference

February 24, 2024 | morningstar.com

Hyperfine Inc Class A HYPR

February 21, 2024 | businesswire.com

Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes

February 11, 2024 | investing.com

HYPR/USD - Hypr Network US Dollar

January 9, 2024 | finance.yahoo.com

Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use

December 1, 2023 | benzinga.com

Hyperfine Stock (NASDAQ:HYPR) Earnings Dates and Earning Calls

December 1, 2023 | markets.businessinsider.com

Maintaining Hold on Hyperfine: Weighing Swoop MRI’s Market Entry Challenges Against Future Growth Prospects

November 30, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ)

November 30, 2023 | benzinga.com

Hyperfine Stock (NASDAQ:HYPR) Dividends: History, Yield and Dates

November 30, 2023 | msn.com

Jefferies starts Hyperfine at hold, says company still in early commercial stage

November 30, 2023 | msn.com

Jefferies Initiates Coverage of Hyperfine Inc - (HYPR) with Hold Recommendation

November 20, 2023 | finance.yahoo.com

Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023

November 16, 2023 | finance.yahoo.com

Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference

November 12, 2023 | finance.yahoo.com

Hyperfine, Inc. (NASDAQ:HYPR) Q3 2023 Earnings Call Transcript

November 9, 2023 | finance.yahoo.com

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results

See More Headlines

Receive HYPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/21/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/09/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:HYPR
CUSIP: N/A
CIK: 1833769
Web: hyperfine.io
Phone: 866-796-6767
Fax: N/A
Employees: 131
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $2.12
High Stock Price Target: $3.50
Low Stock Price Target: $1.25
Potential Upside/Downside: +140.5%
Consensus Rating: Hold
Rating Score (0-4): 2.33
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.62)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-44,240,000.00
Net Margins: -401.00%
Pretax Margin: -401.00%
Return on Equity: -44.89%
Return on Assets: -40.96%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 10.14
Quick Ratio: 9.39

Sales & Book Value

Annual Sales: $11.03 million
Price / Sales: 5.74
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.17 per share
Price / Book: 0.75

Miscellaneous

Outstanding Shares: 71,950,000
Free Float: 52,883,000
Market Cap: $63.32 million
Optionable: Optionable
Beta: 0.75

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. R. Scott Huennekens CPA (Age 60)
M.B.A., Executive Chairman
Comp: $1.29M
Ms. Maria Sainz (Age 58)
CEO, President & Director
Comp: $340.24k
Dr. Jonathan M. Rothberg Ph.D. (Age 60)
Founder & Vice Chairman
Comp: $51.37k
Mr. Brett Hale (Age 50)
Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary
Mr. Chip Truwit FACR
M.D., Vice President of Scientific Affairs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HYPR Stock Analysis - Frequently Asked Questions

Should I buy or sell Hyperfine stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hyperfine in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HYPR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HYPR, but not buy additional shares or sell existing shares.
View HYPR analyst ratings or view top-rated stocks.
What is Hyperfine's stock price target for 2024?: 3 Wall Street research analysts have issued twelve-month target prices for Hyperfine's shares. Their HYPR share price targets range from $1.25 to $3.50. On average, they predict the company's share price to reach $2.12 in the next twelve months. This suggests a possible upside of 155.0% from the stock's current price.
View analysts price targets for HYPR or view top-rated stocks among Wall Street analysts.
How have HYPR shares performed in 2024?: Hyperfine's stock was trading at $1.12 at the beginning of 2024. Since then, HYPR stock has decreased by 25.9% and is now trading at $0.83.
View the best growth stocks for 2024 here.
When is Hyperfine's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our HYPR earnings forecast.

How were Hyperfine's earnings last quarter?: Hyperfine, Inc. (NASDAQ:HYPR) announced its quarterly earnings data on Thursday, March, 21st. The company reported ($0.15) EPS for the quarter, beating analysts' consensus estimates of ($0.17) by $0.02. The business earned $2.69 million during the quarter, compared to analysts' expectations of $3.66 million. Hyperfine had a negative trailing twelve-month return on equity of 44.89% and a negative net margin of 401.00%.
What guidance has Hyperfine issued on next quarter's earnings?: Hyperfine updated its FY 2024 earnings guidance on Thursday, March, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $12.0 million-$15.0 million, compared to the consensus revenue estimate of $18.4 million.
How do I buy shares of Hyperfine?: Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HYPR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Hyperfine (HYPR) Stock Price, News & Analysis

Hyperfine MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Hyperfine Stock (NASDAQ:HYPR)

HYPR Stock Price History

HYPR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

HYPR Stock Analysis - Frequently Asked Questions

Overall MarketRank^™